MIR4763 Gene

HGNC Family Non-coding RNAs
Name microRNA 4763
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAlthough none of the abstracts directly mention MIR4763, the studies collectively illuminate molecular mechanisms governing immune cell activation and tolerance that may inform potential roles for this microRNA. For example, the work by described in PMID"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "demonstrates that NK cell activation depends on Fyn‐mediated signals that promote the acquisition of inhibitory receptors until sufficient self‐MHC recognition is achieved, suggesting that fine‐tuning of signaling thresholds is critical. In this context, MIR4763 may be hypothesized to contribute to the post‐transcriptional regulation of key signaling mediators or receptor expression that underpin this balance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurther insights arise from studies of allelic variation and post‐translational modifications of Ly49 receptors. The differential ligand specificity due to amino acid polymorphisms in extracellular domains (PMID"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "and the modulation of receptor–ligand affinity via glycosylation (PMID"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "highlight complex regulatory networks that refine immune cell responsiveness. Such multifaceted control implies that additional regulators including microRNAs like MIR4763 could target transcripts involved in receptor maturation or modification, thereby adjusting signaling outputs.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, the coordinated regulation of activating and inhibitory receptors extends beyond NK cells to other lymphocytes, affecting cell migration and maturation (PMID."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Equally, the comparable binding affinities reported for activating versus inhibitory receptors (PMID"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "underscore a balance that is essential for immune tolerance and defense. In aggregate, these findings provide a conceptual framework in which MIR4763 might function as a fine‐tuner within these networks, potentially regulating transcript levels of key kinases, receptors, or adapter molecules to ensure proper signal integration and immune homeostasis.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Bente Lowin-Kropf, Béatrice Kunz, Pascal Schneider, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1521-4141(200203)32:3"}, {"type": "a", "children": [{"type": "t", "text": "773::AID-IMMU773"}], "href": "773::AID-IMMU773"}, {"type": "t", "text": "3.0.CO;2-U"}], "href": "https://doi.org/10.1002/1521-4141(200203"}, {"type": "t", "text": "32:3"}, {"type": "a", "children": [{"type": "t", "text": "773::AID-IMMU773"}], "href": "773::AID-IMMU773"}, {"type": "t", "text": "3.0.CO;2-U) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11870621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11870621"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Elizabeth T Silver, Kerry J Lavender, Dong-Er Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.169.9.4752"}], "href": "https://doi.org/10.4049/jimmunol.169.9.4752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12391184"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12391184"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Llewellyn H Mason, Jami Willette-Brown, Stephen K Anderson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Receptor glycosylation regulates Ly-49 binding to MHC class I."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.171.8.4235"}], "href": "https://doi.org/10.4049/jimmunol.171.8.4235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14530347"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14530347"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Gili Hart, Liat Flaishon, Shirly Becker-Herman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tight regulation of IFN-gamma transcription and secretion in immature and mature B cells by the inhibitory MHC class I receptor, Ly49G2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.175.8.5034"}], "href": "https://doi.org/10.4049/jimmunol.175.8.5034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16210606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16210606"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Brian J Ma, Carla M Craveiro Salvado, Kevin P Kane "}, {"type": "b", "children": [{"type": "t", "text": "The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunogenetics (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00251-014-0777-2"}], "href": "https://doi.org/10.1007/s00251-014-0777-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24797174"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24797174"}]}]}]}
NCBI Gene ID 100616143
API
Download Associations
Predicted Functions View MIR4763's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR4763's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR4763's ARCHS4 Predicted Functions.

Functional Associations

MIR4763 has 381 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.

Click the + buttons to view associations for MIR4763 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4763 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4763 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4763 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR4763 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR4763 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR4763 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4763 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of MIR4763 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4763 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.